Large scale controlled Fab exchange GMP process to prepare bispecific antibodies
Objective: Bispecific antibodies (BsAbs) have demonstrated significant therapeutic impacts for the treatment of a broad spectrum of diseases that include oncology, auto-immune, and infectious diseases. However, the large-scale production of clinical batches of bispecific antibodies still has many ch...
Main Authors: | Xia Yao, Mingquan Xie, Yinyin Ben, Yixiang Zhu, Gaoqiang Yang, Simon Chi Wai Kwong, Zhengliang Zhang, Mark L. Chiu |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2024-01-01
|
Series: | Frontiers in Bioengineering and Biotechnology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fbioe.2023.1298890/full |
Similar Items
-
Bispecific antibodies with Fab-arms featuring exchanged antigen-binding constant domains
by: Filippo Benedetti, et al.
Published: (2021-07-01) -
Facile Generation of Potent Bispecific Fab via Sortase A and Click Chemistry for Cancer Immunotherapy
by: Xuefei Bai, et al.
Published: (2021-09-01) -
Prevention of Fab-arm exchange and antibody reduction via stabilization of the IgG4 hinge region
by: Michael W. Handlogten, et al.
Published: (2020-01-01) -
Greatest Hits—Innovative Technologies for High Throughput Identification of Bispecific Antibodies
by: Tim Hofmann, et al.
Published: (2020-09-01) -
Site-specific PEGylation of an anti-CEA/CD3 bispecific antibody improves its antitumor efficacy
by: Pan H, et al.
Published: (2018-05-01)